ALX Oncology

About:

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Website: http://alxoncology.com/

Twitter/X: alxoncology

Top Investors: Cormorant Asset Management, Foresite Capital, Biotechnology Value Fund, Silicon Valley Bank, Janus Henderson Investors

Description:

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company. The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University. This discovery involves soluble versions of signal regulatory protein-α (SIRPα) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPα.1.